The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

In an age where smartphones have become an extension of ourselves, the idea of stepping away from them-even briefly-can seem ...

For more news like this visit TOI. Get all the Latest News, City News, India News, Business News, and Sports News. For ...

Feeling drained, anxious, or irritable? You might be overstimulated! Learn how to identify and manage sensory overload for ...

This study presents a valuable theoretical exploration on the electrophysiological mechanisms of ionic currents via gap junctions in hippocampal CA1 pyramidal-cell models, and their potential ...

TEDxMarshallU has announced the lineup of inspiring speakers for its 7th annual event, “Beyond Borders.” Eight speakers will ...

A 34-year-old woman with a 2-year history of progressively worsening difficulties in walking, eating and swallowing, ...